Eden Research (LON:EDEN) Shares Down 3.3% – What’s Next?

Shares of Eden Research plc (LON:EDEN) were down 3.3% during trading on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The firm has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The firm’s fifty day moving average is GBX 3.87 and its 200 day moving average is GBX 3.95.

Insider Buying and Selling

In related news, insider Lykele van der Broek purchased 256,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). 14.02% of the stock is currently owned by corporate insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.